Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

FDA begins data initiative with millions of adverse event reports

Will provide web developers and others with access to large public health datasets
575639

Web developers, researchers and the public will now have easier access to FDA public health datasets thanks to the US regulator's new open data initiative.

The openFDA project began this week with the release of millions of reports of drug adverse events and medication errors that have been submitted to the FDA between 2004 and 2013.

The data had previously been available, but only through a difficult-to-use reporting system or via Freedom of Information Act requests.

Taha Kass-Hout, the FDA's chief health informatics officer, said: "Through this new and novel approach to data organisation, these reports will be available in their entirety so that software developers can build tools to help signal potential safety information, derive meaningful insights, and get information to consumers and healthcare professionals in a timely manner.

"OpenFDA offers a scalable platform that can be easily searched and queried across many distinct datasets, and can be easily redeployed or altered to fit a variety of purposes, and provides an innovative public data search and analytics solution."

The first release of data will followed by the FDA's databases on product recalls and product labelling, with the whole project coming in the way of the Presidential Executive Order on Open Data and the Department of Health and Human Services' Health Data Initiative.

The openFDA website makes the FDA's publicly available data accessible in a structured, computer readable format through a search-based application program interface (API).

The regulator says this will make it possible for the likes of mobile application creators, web developers, data visualisation artists and researchers to quickly search and make use of public information contained in the FDA's datasets.

4th June 2014

From: Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To transform lives through communication that changes behaviour and improves health outcomes....

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....